Free shipping on all orders over $ 500

Nastorazepide

Cat. No. M29195

All AbMole products are for research use only, cannot be used for human consumption.

Nastorazepide Structure
Synonym:

Z-360

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

Nastorazepide (Z-360) is a selective, orally available, 1,5-benzodiazepine-derivative gastrin/cholecystokinin 2 (CCK-2) receptor antagonist with potential antineoplastic activity. Target:CCK-2 in vitro: Z-360 binds to the gastrin/CCK-2 receptor, thereby preventing receptor activation by gastrin, a peptide hormone frequently associated with the proliferation of gastrointestinal and pancreatic tumor cells. Check for active clinical trials or closed clinical trials using this agent. in vivo: Z-360 is a novel orally active CCK-2/gastrin receptor antagonist, significantly inhibits the growth of subcutaneous xenografts of human pancreatic tumor cells in mice, and that Z-360 combined with gemcitabine prolonged survival in a pancreatic carcinoma orthotopic xenograft mice.

Chemical Information
Molecular Weight 520.62
Formula C29H36N4O5
CAS Number 209219-38-5
Form Solid
Solubility (25°C) DMSO ≥ 32 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Marco Verona, et al. Molecules. Preliminary Study of a 1,5-Benzodiazepine-Derivative Labelled with Indium-111 for CCK-2 Receptor Targeting

[2] Doroteja Novak, et al. ChemMedChem. Radiolabelled CCK2 R Antagonists Containing PEG Linkers: Design, Synthesis and Evaluation

Related Cholecystokinin Receptor Products
Pentagastrin

Pentagastrin (ICI-50123) is a synthetic polypeptide that has effects like gastrin when given parenterally.

Proglumide sodium salt

Proglumide sodium salt is a non-selective, orally active cholecystokinin (CCK) antagonist.

Lintitript

Lintitript (SR 27897) is a highly potent, selective, orally active, competitive and non-peptide cholecystokinin (CCK1) receptor antagonist with an EC50 of 6 nM and a Ki of 0.2 nM. Lintitript displays > 33-fold selectivity more selective for CCK1 than CCK2 receptors (EC50 value of 200 nM).

Lorglumide sodium salt

Lorglumide (CR-1409) sodium salt is a potent cholecystokinin (CCK) receptor antagonist.

Gastrin-I (human)

Gastrin-I (human) is the endogenous peptide produced in the stomach, which increases gastric acid secretion via cholecystokinin 2 (CCK2) receptor.

  Catalog
Abmole Inhibitor Catalog




Keywords: Nastorazepide, Z-360 supplier, Cholecystokinin Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.